RVPH Stock Analysis: Buy, Sell, or Hold?
RVPH - Reviva Pharmaceuticals Holdings, Inc. Common Stock
$0.81
0.08 (10.96%)
▲
5d:
-2.27%
30d:
+276.08%
90d:
+191.26%
BUY
HIGH Confidence
Analysis Updated: Apr 1, 2026 12:00 AM ET
Earnings: Mar 30, 2026
0d
Smart Money Accumulation
RVPH is down 33.5% this week, but smart money is accumulating calls. Top strike: $1 2026-04-17 with 24,439 OI. Call ratio: 100% View Scanner →
Strength: 10.0/10
Get Alerted When RVPH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: RVPH shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: RVPH shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: RVPH is currently trading at $0.81, which is considered fair relative to its 30-day fair value range of $0.07 to $2.02.
Technical Outlook: Technically, RVPH is in a strong downtrend. Immediate support is located at $0.59, while resistance sits at $0.94. The stock is showing strong short-term momentum, up 11.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $95.00 (+11632.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, RVPH is in a strong downtrend. Immediate support is located at $0.59, while resistance sits at $0.94. The stock is showing strong short-term momentum, up 11.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $95.00 (+11632.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$0.07 -
$2.02
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
80.0%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+11.0%)
- BULLISH: Trading 11632.7% below Wall St target ($95.00)
Fair Price Analysis
30-Day Fair Range
$0.07 -
$2.02
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$0.59
Resistance Level
$0.94
Current Trend
Strong Downtrend
Technical data as of
Apr 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.21
Wall Street Target
$95.00
(+11632.7%)
Share & Embed Analysis
Last updated: April 02, 2026 6:04 AM ET
Data refreshes hourly during market hours. Next update: 7:04 AM
Data refreshes hourly during market hours. Next update: 7:04 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RVPH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$89 | 63 BUY |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$58 | 65 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$84 | 62 BUY |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$547 | 52 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$119 | 59 HOLD |
